Abstract 5211
Background
Neoadjuvant chemotherapy (NAC) followed by cystectomy is the standard of care in MIBC patients, although a limited survival benefit has been obtained compared with cystectomy alone. Pathologic response has been associated with survival, but, unfortunately, neither baseline clinical or pathological variables have demonstrated ability to predict which patients will benefit from NAC, pointing to the need of predictive biomarkers of NAC response to guide treatment decisions. The objective of this retrospective study was to identify a NAC response prediction signature integrating baseline clinical features, taxonomic subtypes, and RNA expression profile in MIBC patients.
Methods
Formalin-fixed paraffin-embedded pre-treatment tumor samples were collected by transurethral resection from 112 patients with MIBC stage T2-4N0/+M0 treated with NAC followed by cystectomy. Immunohistochemical-based taxonomic subtypes (BASQ-like, luminal-like, mixed) were established. Gene expression analysis was performed on the Nano String nCounter platform. A custom code set of a 41-gene panel involved in the DNA damage repair (DDR) and immune response pathways was used. Lasso and elastic net penalized logistic regression were performed to identify a predictive signature. Calculation of the area under the ROC curve (AUC) was used to assess the predictive ability of the signature.
Results
A nine-gene RNA expression signature (RAD51, CXCL9, PARP, 53BP1, HERC2, ERCC2, CHEK1, Ku80 and RNF 168 genes) was associated with pathologic response. The highest predictive ability was observed with the integrated clinical-taxonomical-RNA signature with an AUC of 0.66, in comparison to the clinical-taxonomical classification (AUC=0.58) or the clinical signature alone (AUC=0.52). Furthermore, the integrated signature was significantly associated with overall survival (p = 0.013).
Conclusions
We have identified a nine-gene RNA expression signature that can help to predict response in MIBC patients treated with NAC. Prospective studies are warranted to validate these results.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
AECC.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2494 - CAR-T Nursing Education at a UK Specialist Cancer Hospital
Presenter: Rose Ellard
Session: Poster Display session 3
Resources:
Abstract
2438 - Professional Quality of Life, Perceived Stress and Psychological Resistance Levels of Oncology-Hematology Nurses and the Factors Affecting
Presenter: Tugba Pehlivan
Session: Poster Display session 3
Resources:
Abstract
3541 - Representation of cancer survivors’ preferences in policies for supportive care: Implications for oncology nursing
Presenter: Samantha Mayo
Session: Poster Display session 3
Resources:
Abstract
5093 - Vaginal moisturizing post PDR-Pulse Dose Rate Brachytherapy.
Presenter: Pilar Fernández
Session: Poster Display session 3
Resources:
Abstract
1066 - The stomized, chemo and radiotreated patient vs untreated patient: complications and comparison with data literature
Presenter: Cristoforo Ferrero
Session: Poster Display session 3
Resources:
Abstract
1724 - Evaluating the role of clinical nurse specialist
Presenter: Anita Zeneli
Session: Poster Display session 3
Resources:
Abstract
3753 - Role of the Advanced Practice Nurse (APN) in a Functional Unit for Lung cancer at the Catalan Institute of Oncology
Presenter: Isabel Brao
Session: Poster Display session 3
Resources:
Abstract
2676 - A bottom-up approach for prioritising the scientific activities of the Italian Association of Cancer Nurses (AIIAO): rationale and topic identification
Presenter: Valentina Biagioli
Session: Poster Display session 3
Resources:
Abstract
575 - Investigating quality of care for people with cancer and dementia
Presenter: Naomi Farrington
Session: Poster Display session 3
Resources:
Abstract
5578 - Two years of BRCA1 and BRCA2 somatic External Quality Assessment with Gen&tiss Tiss scheme in France
Presenter: Kelly Dufraing
Session: Poster Display session 3
Resources:
Abstract